JCM
LNAI

Jacobi Capital Management’s Lunai Bioworks LNAI Stock Holding History

Jacobi Capital Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-83
Closed -$45K – 1110
2021
Q3 		$45K Buy
83
+27
+48% +$13.2K 0.01% 675
2021
Q2 		$22K Buy
+56
New +$18.2K ﹤0.01% 819

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jacobi Capital Management's LNAI Position: Q4 2021 in Review

Jacobi Capital Management sold out of Lunai Bioworks (LNAI) in Q4 2021, closing a stake of 83 shares — an estimated $45K sold.

Jacobi Capital Management first reported a position in LNAI in Q2 2021 and held it in 2 quarters. The position peaked at $45K in Q3 2021. 44 funds tracked by Wall St. Rank hold LNAI as of Q4 2021.

  • Jacobi Capital Management reported no remaining Lunai Bioworks position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 83 Lunai Bioworks shares in Q4 2021, an estimated $45K.
  • Jacobi Capital Management first reported a position in Lunai Bioworks in Q2 2021 and held it in 2 quarters.
  • Jacobi Capital Management's Lunai Bioworks position peaked at $45K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.